Transient Ischemic Attack
|
0.200 |
Biomarker
|
disease |
RGD |
Co-induction of p75NTR and p75NTR-associated death executor in neurons after zinc exposure in cortical culture or transient ischemia in the rat.
|
11124986 |
2000 |
Glaucoma
|
0.200 |
Biomarker
|
disease |
RGD |
Does elevated intraocular pressure reduce retinal TRKB-mediated survival signaling in experimental glaucoma?
|
19682984 |
2009 |
Visual seizure
|
0.200 |
Therapeutic
|
disease |
RGD |
Co-induction of p75(NTR) and the associated death executor NADE in degenerating hippocampal neurons after kainate-induced seizures in the rat.
|
12873743 |
2003 |
Neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Collectively, curcumin, a safe nutraceutical has the potential to induce all endogenous Bex genes to harness their anti-cancer properties in neuroblastoma cells.
|
28145533 |
2017 |
Tuberous Sclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results indicate that hamartin binds to NADE to regulate neuronal cell function and loss of this association is likely to contribute to the brain pathology in TSC.
|
17355907 |
2007 |
Papillary thyroid carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Relapse-free survival analyses found that 11 genes (KCNQ3, MET, FN1, ITGA3, RUNX1, ITGA2, PERP, GCSH, FAAH, NGFRAP1, and HSPA5) may play a pivotal role in PTC relapse.
|
31332712 |
2019 |
Central neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Collectively, curcumin, a safe nutraceutical has the potential to induce all endogenous Bex genes to harness their anti-cancer properties in neuroblastoma cells.
|
28145533 |
2017 |
Nasopharyngeal carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In cisplatin-resistant NPC xenograft, treatment with nontoxic level of cisplatin led to a remarkable increase in BEX3 level.
|
28083995 |
2017 |
Childhood Neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Collectively, curcumin, a safe nutraceutical has the potential to induce all endogenous Bex genes to harness their anti-cancer properties in neuroblastoma cells.
|
28145533 |
2017 |
Malignant Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
BEX3 overexpression was a unique event in cancer developed in the head and neck regions, especially NPC.
|
28083995 |
2017 |
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
Role of any Bex gene in neuroblastoma and Bex4 and Bex6 in any cancer is completely unknown.
|
28145533 |
2017 |
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
BEX3, in comparison, was overexpressed in the primary tumor.
|
27297407 |
2016 |
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
Re-expression of Bex genes by curcumin acts as tumor suppressors and may provide alternate strategy to treat neuroblastomas and other cancers with silenced Bex genes.
|
28145533 |
2017 |
Primary malignant neoplasm
|
0.020 |
AlteredExpression
|
group |
BEFREE |
BEX3 overexpression was a unique event in cancer developed in the head and neck regions, especially NPC.
|
28083995 |
2017 |
Primary malignant neoplasm
|
0.020 |
Biomarker
|
group |
BEFREE |
Role of any Bex gene in neuroblastoma and Bex4 and Bex6 in any cancer is completely unknown.
|
28145533 |
2017 |